ABIVAX Société Anonyme (LON:0RA9)
London · Delayed Price · Currency is GBP · Price in EUR 105.40
+7.10 (7.22%)
Feb 12, 2026, 5:09 PM GMT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of 7.05 billion as of February 12, 2026. Its market cap has increased by 2,193.52% in one year.
Market Cap
7.05B
Enterprise Value
6.60B
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
105.40
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 143.21M to 7.05B, an increase of 4,823.77%. That is a compound annual growth rate of 44.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.65B | -18.70% |
| Dec 31, 2025 | 8.17B | 2,208.80% |
| Dec 31, 2024 | 354.07M | -33.68% |
| Dec 29, 2023 | 533.84M | 480.61% |
| Dec 30, 2022 | 91.95M | -76.57% |
| Dec 31, 2021 | 392.37M | -7.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.48B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.88B |